Calidi Biotherapeutics (CLDI) Current Leases (2022 - 2026)
Calidi Biotherapeutics (CLDI) posted quarterly Current Leases of $1.4 million for Q4 2025, up 16.69% year-over-year from $1.2 million in Q4 2024, and up 3.77% quarter-over-quarter from $1.4 million in Q3 2025.
Calidi Biotherapeutics (CLDI) Current Leases (2022 - 2026) Analysis & Trends
Calidi Biotherapeutics' Current Leases history runs 4 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- In Q4 2025, Current Leases rose 16.69% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (up 16.69% YoY), while the FY2025 annual figure was $1.4 million, up 16.69% from the prior year.
- Current Leases for Q4 2025 stood at $1.4 million, up from $1.4 million in the prior quarter.
- The five-year high for Current Leases was $1.4 million in Q4 2025, with the low at $47000.0 in Q3 2022.
- The 4-year median for Current Leases is $73000.0 (2022), against an average of $491571.4.
- The sharpest annual moves came in 2023 and 2024: Current Leases soared 2014.89% in 2023, then plunged 93.06% in 2024.
- Calidi Biotherapeutics' Current Leases stood at $72000.0 in 2022, then increased by 12.5% to $81000.0 in 2023, then soared by 1386.42% to $1.2 million in 2024, then climbed by 16.69% to $1.4 million in 2025.
- Business Quant data shows CLDI's Current Leases at $1.4 million in Q4 2025, $1.4 million in Q3 2025, and $1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | 1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Mn |
| Dec 31, 2025 | 1.41 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 69,000.00 |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 69,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Mar 31, 2024 | 74,000.00 |
| Dec 31, 2023 | 81,000.00 |
| Sep 30, 2023 | 994,000.00 |
| Jun 30, 2023 | 70,000.00 |
| Mar 31, 2023 | 71,000.00 |
| Dec 31, 2022 | 72,000.00 |
| Sep 30, 2022 | 47,000.00 |